Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

24.24

-0.08 (-0.33%)

At close: Mar 6, 2026, 4:00 PM EST

24.00

-0.24 (-0.99%)

After-hours: Mar 6, 2026, 7:53 PM EST

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $2.96 billion as of March 6, 2026. Its market cap has increased by 10.16% in one year.

Market Cap

2.96B

Enterprise Value

2.25B

1-Year Change

10.16%

Ranking

#1733

Market Cap Chart

Since November 8, 2006, Catalyst Pharmaceuticals's market cap has increased from $76.40M to $2.96B, an increase of 3,774.72%. That is a compound annual growth rate of 20.82%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	2.97B	3.53%
Dec 31, 2025	2.87B	15.25%
Dec 31, 2024	2.49B	38.90%
Dec 29, 2023	1.79B	-7.42%
Dec 30, 2022	1.94B	177.28%
Dec 31, 2021	698.10M	101.65%
Dec 31, 2020	346.20M	-10.40%
Dec 31, 2019	386.40M	95.84%
Dec 31, 2018	197.30M	-40.80%
Dec 29, 2017	333.30M	283.10%
Dec 30, 2016	87.00M	-57.12%
Dec 31, 2015	202.90M	-1.17%
Dec 31, 2014	205.30M	94.41%
Dec 31, 2013	105.60M	599.34%
Dec 31, 2012	15.10M	-52.66%
Dec 30, 2011	31.90M	66.15%
Dec 31, 2010	19.20M	68.42%
Dec 31, 2009	11.40M	-54.94%
Dec 31, 2008	25.30M	-41.44%
Dec 31, 2007	43.20M	-28.60%
Dec 29, 2006	60.50M	-20.81%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Spyre Therapeutics	3.15B
Denali Therapeutics	3.12B
Tarsus Pharmaceuticals	3.12B
Edgewise Therapeutics	2.98B
Arcutis Biotherapeutics	2.98B
IDEAYA Biosciences	2.92B
Viridian Therapeutics	2.90B
Dianthus Therapeutics	2.82B

Market Cap Rankings